Planes carrying Corona vaccine leave in preparation for zero hours – Covid-19

After the German company Biontec and the American company Pfizer previously confirmed that the vaccine could be marketed in December, it seems that preparations have started in full swing.

Today, Saturday, US media reported that US “United Airlines” planes have started transporting thousands of doses of Pfizer’s Corona virus vaccine, and collecting them at specific centers, with the aim of speeding up the distribution process later.

In this context, the Wall Street Journal cited knowledgeable sources claiming that these first trips were launched within a large global supply chain being planned, to address any difficulties or challenges that may hinder delivery of the vaccine, which requires specific storage conditions.

According to the newspaper, the distribution plan identified cold storage sites at final assembly centers in several regions, such as Michigan in the United States and the port in Belgium, in addition to Karlsruhe in Germany, among others.

Additionally, the Federal Aviation Administration said in a statement that it is working with airlines to transport vaccines safely. While the newspaper revealed that United Company had obtained permission to transport quantities of dry ice in excess of what is normally allowed during flights, in order to maintain the very low temperatures required by the conditions of storage and transport of the vaccine (70 degrees below zero), according to Al Arabiya Net.

It should be noted that the storage and transport conditions of Pfizer vaccine require exceptional temperatures that vaccines generally do not require. UK Health Minister Matt Hancock spoke in a television interview last week about a very significant obstacle to transporting the Pfizer / Bionic vaccine from where it was manufactured to the people who will receive it, stressing that it must remain stored at a temperature of 70 degrees below zero, and that it can not be Put it at a higher temperature more than four times during its transport trip.

There is no doubt that this necessary condition for the conservation of this vaccine, which has formed a door of hope for millions of people around the world, represents an absolutely insignificant obstacle to the process of transferring factories to hospitals.

This issue represents a major challenge for many countries, given that most of the known vaccines do not require a low temperature and therefore most hospitals do not include the infrastructure to allow them to manage this new vaccine.